scripod.com

Improving Science & Restoring Trust in Public Health | Dr. Jay Bhattacharya

Huberman Lab

2025/06/09
Huberman Lab

Huberman Lab

2025/06/09

Shownote

My guest is Dr. Jay Bhattacharya, MD, PhD, Director of the National Institutes of Health (NIH) and Professor Emeritus of Health Policy at Stanford University. We discuss which scientific questions ought to be the priority for NIH, how to incentivize bold, ...

Highlights

Dr. Jay Bhattacharya, the new Director of the National Institutes of Health (NIH) and former Stanford professor, joins the conversation to address critical issues in biomedical research and public health. The discussion explores how the NIH can better support scientific innovation, improve transparency, and rebuild public trust, especially in the wake of the COVID-19 pandemic. Topics include funding priorities, structural challenges in research, and the need for reform in how science is conducted and communicated.
00:00
Restoring public trust in science is essential for future progress.
06:56
Jay emphasizes the NIH's long-standing importance in biomedical research
09:14
Basic research funded by NIH is not patentable but essential for long-term health advancements
25:01
Stanford has a 55% indirect cost rate on NIH grants, significantly increasing taxpayer expenditure
33:33
NIH-funded journal publications will be free to the public starting in July
44:48
American taxpayers largely fund global basic and late-stage research through NIH and high drug prices.
48:50
President Trump issued an executive order to equalize global drug prices through trade and re-importation policies.
1:05:44
Across-the-board IDC cuts may harm less wealthy universities
1:18:48
R01 proposals often involve work already completed.
1:27:10
Young scientists are more likely to make discoveries due to brain plasticity, energy, and dopamine.
3:09:47
Public health messaging during the pandemic lacked scientific basis, undermining trust in science.

Chapters

Jay Bhattacharya
00:00
National Institutes of Health (NIH), Mission
06:56
Funding, Basic vs. Applied Research
09:12
Sponsors: David & Eight Sleep
18:22
Indirect Costs (IDC), Policies & Distribution
21:20
Taxpayer Funding, Journal Access, Public Transparency
30:43
Taxpayer Funding, Patents; Drug Costs in the USA vs Other Countries
38:14
Reducing Medication Prices; R&D, Improving Health
48:50
Sponsors: AG1 & Levels
1:00:01
Lowering IDC?, Endowments, Monetary Distribution, Scientific Groupthink
1:02:55
Grant Review Process, Innovation
1:12:29
R01s, Tenure, Early Career Scientists & Novel Ideas
1:21:43
Sociology of Grant Evaluation, Careeri
1:31:46

Transcript

Jay Bhattacharya: Since 2012, there's been no increase in American life expectancy. From 2012 to 2019, literally, it was almost entirely flat life expectancy, whereas the European countries had advances in life expectancy during that period. During the pan...